Latest Posts
About This Stock
More About This Stock
Read
Read
The Week Ahead In Biotech: Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Article By:
Benzinga
Sunday, August 15, 2021 5:54 PM EDT
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small- and mid-cap companies among those that reported during the week.
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Article By:
Benzinga
Sunday, June 20, 2021 11:19 AM EDT
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries.
In this article: ALNY, DRRX, NVAX, ABBV, RGLS, RDUS, CAPR, NTLA, ABUS, ASND, ASMB, AKRO, FULC, VIR, DAWN, OMIC, CNTA, IVA, IPHA